[Corrigendum] Combination of the FGFR4 inhibitor PD173074 and 5‑fluorouracil reduces proliferation and promotes apoptosis in gastric cancer

Ye,Yan-Wei; Hu,Shuang; Shi,Ying-Qiang; Zhang,Xie-Fu; Zhou,Ye; Zhao,Chun-Lin; Wang,Guo-Jun; Wen,Jian-Guo; Zong,Hong

doi:10.3892/or.2026.9215

December-2026 Volume 56 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December-2026 Volume 56 Issue 6

Full Size Image

Correction Open Access

[Corrigendum] Combination of the FGFR4 inhibitor PD173074 and 5‑fluorouracil reduces proliferation and promotes apoptosis in gastric cancer

Authors:
- Yan-Wei Ye
- Shuang Hu
- Ying-Qiang Shi
- Xie-Fu Zhang
- Ye Zhou
- Chun-Lin Zhao
- Guo-Jun Wang
- Jian-Guo Wen
- Hong Zong
View Affiliations / Copyright

Affiliations: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of Stomach and Soft Tissue Sarcoma Surgery, Shanghai Cancer Center, Fu Dan University, Shanghai 200032, P.R. China

Copyright: © Ye et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 209
|
Published online on: October 26, 2026

https://doi.org/10.3892/or.2026.9215
Expand metrics +

Article

Oncol Rep 30: [Related article:] 2777-2784, 2013; DOI: 10.3892/or.2013.2796

Following the publication of the above article, and an Expression of concern statement (doi: 10.3892/or.2025.9004) that was published after a concerned reader drew the Editor's attention to the fact that, for the western blot data shown in Figs. 1E and 4, the FGFR blots and the control GAPDH blots appeared to be strikingly similar, suggesting that the same data had been included in these figures even though the results from differently performed experiments were intended to have been portrayed, the authors have now responded to the Editorial Office to address this issue. Owing to the similarities in these data, the authors have repeated the experiments shown in Fig. 1E, and the revised version of Fig. 1 including this figure part is shown below. Note that the revisions made to this figure do not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and all the authors agree with its publication; furthermore, they apologize to the readership for any inconvenience caused.

Figure 1.

Expression of FGFR4 mRNA and protein in gastric cancer cell lines, MKN45, SGC7901, SNU-1 and SNU-16. Expression of FGFR4 mRNA in the different GC cell lines was revealed by (A) RT-PCR and (B) quantitative real-time PCR. (C and D) Illustrated melting curve and quantification curve of FGFR4, respectively. (E) Expression of FGFR4 protein in the different GC cell lines was assessed by western blot analysis; GAPDH served as the loading control. Expression of FGFR4 mRNA and protein in MKN45 cells was the highest among the 4 GC cell lines.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Combination of the FGFR4 inhibitor PD173074 and 5‑fluorouracil reduces proliferation and promotes apoptosis in gastric cancer

This article is mentioned in:

Article

Figure 1.

Related Articles